Related Experiment Video

Updated: May 31, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

New drugs for breast cancer subtypes: targeting driver pathways to overcome resistance

Giuseppe Curigliano1

  • 1Division of Medical Oncology, Department of Medicine, European Institute of Oncology, Milan, Italy. giuseppe.curigliano@ieo.it

Cancer Treatment Reviews
|July 19, 2011
PubMed

Insights

Breast cancer comprises diverse subtypes, each with unique molecular drivers. Identifying these drivers is key to developing targeted therapies and personalized treatment approaches for better patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Breast cancer is a heterogeneous disease, not a single entity.
  • Genetic array tools enable the classification of breast cancer into distinct molecular subtypes.
  • Each subtype exhibits unique biological processes, gene pathways, and responses to therapies.

Purpose of the Study:

  • To review emerging agents targeting driver pathways in breast cancer molecular subtypes.
  • To highlight the importance of distinguishing cancer-driving genes from passenger genes for drug development.
  • To emphasize personalized therapeutic strategies based on molecular sub-classification.

Main Methods:

  • Review of current literature on breast cancer molecular subtypes.
  • Analysis of genetic array data to define subtypes and associated pathways.
  • Identification of "driver" vs. "passenger" genes and pathways.
  • Evaluation of targeted agents and their efficacy in specific subtypes.

Main Results:

  • Molecular classification of breast cancer reveals distinct subtypes with varying prognoses and treatment sensitivities.
  • Identification of functional pathways enriched for mutated genes aids in selecting patient subpopulations for targeted therapies.
  • Understanding driver pathways in resistant tumors facilitates the development of novel therapeutic strategies.
  • Personalized treatment approaches are crucial for managing diverse breast cancer subtypes.

Conclusions:

  • Breast cancer subtypes necessitate individualized therapeutic strategies.
  • Targeting molecularly defined driver pathways offers a promising avenue for novel drug development.
  • Distinguishing driver from passenger mutations is critical for effective targeted therapy selection.
  • Future drug development should focus on biology-driven platforms to overcome treatment resistance.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.